Management of Temporomandibular Disorders (TMD)
Continuous Versus Pulsed Dexamethasone Phonophoresis in Management of TMD. A Comparative Clinical Study
1 other identifier
interventional
80
1 country
1
Brief Summary
Temporomandibular disorders (TMD) are a group of pathologies of the temporomandibular joint, their muscles, and related structures. It is considered a musculoskeletal disorder of the masticatory system, and it has a 25% prevalence in overall population. In 3% - 7% of the population, pain and dysfunction leads to the need for treatment . The etiology of TMD is multifactorial .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 28, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2024
CompletedFirst Submitted
Initial submission to the registry
December 28, 2024
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedJanuary 6, 2025
April 1, 2023
10 months
December 28, 2024
December 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Management of Pain
Pain scores will be recorded on visual analog scale (VAS) using a 0 to 10 pain score basis with 0 being no pain and 10 being the worst pain the patient had ever experienced.
First 24 hours after The Operations
Study Arms (4)
Group A
ACTIVE COMPARATORAbout 20 patients who will receive dexamethasone gel and continuous phonophoresis
Group B
ACTIVE COMPARATORAbout 20 patients who will receive dexamethasone and pulsed phonophoresis
Group C
ACTIVE COMPARATORAbout 20 patients who will receive acoustic gel and continuous phonophoresis
Group D
ACTIVE COMPARATORAbout 20 patients who will receive acoustic gel and pulsed phonophoresis
Interventions
To Compare clinical outcome of dexamethasone phonophoresis in a (continuous and pulsed) maneuver for management of Temporomandibular Disorders
Eligibility Criteria
You may qualify if:
- patients 20- 50 years showing TMD
- pain \> 3 on Visual Analog scale (VAS)
- failed pharmacological treatment
You may not qualify if:
- electrical stimulator or pacemaker
- cancer or any other severe or mental diseases
- osteoarthritis, inflammation, infection, or radiation on the TMJ articulation,
- joint cement or plastic components on TMJ articulation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Faculty of Dentistry, Minia University
Minya, 2431412, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tarek Abdelbarry, Lecturer
Faculty of Dentistry, Minia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Oral and Maxillofacial Surgery
Study Record Dates
First Submitted
December 28, 2024
First Posted
January 6, 2025
Study Start
April 28, 2023
Primary Completion
February 20, 2024
Study Completion
February 28, 2024
Last Updated
January 6, 2025
Record last verified: 2023-04